Skip to main content

Advertisement

SpringerLink
Log in

Netherton syndrome: skin inflammation and allergy by loss of protease inhibition

  • Review
  • Published:
Cell and Tissue Research Aims and scope Submit manuscript

Abstract

Netherton syndrome (NS) is a rare autosomal recessive skin disease with severe skin inflammation and scaling, a specific hair shaft defect and constant allergic manifestations. NS is caused by loss-of-function mutations in SPINK5 (serine protease inhibitor of kazal type 5) encoding LEKTI-1 (lympho-epithelial kazal type related inhibitor type 5) expressed in stratified epithelia. In vitro and in vivo studies in murine models and in NS patients have cast light on the pathogenesis of the disease and shown that LEKTI deficiency results in unopposed kallikrein-related peptidase 5 (KLK5) and KLK7 activities and to the overactivity of a new epidermal protease, elastase 2 (ELA2). Two main cascades initiated by KLK5 activity have emerged. One results in desmoglein 1 degradation and desmosome cleavage leading to stratum corneum detachment. KLK5 also activates KLK7 and ELA2, which contribute to a defective skin barrier. This facilitates allergen and microbe penetration and generates danger signals leading to caspase 1 activation and the production of active interleukin-1β. In parallel, KLK5 activates a specific cascade of allergy and inflammation by activating protease-activated receptor-2 (PAR-2) receptors. PAR-2 activation triggers the production of the major pro-Th2 cytokine TSLP (thymic stromal lymphopoietin) and several inflammatory cytokines, including tumour necrosis factor-α. Levels of thymus and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC) also contribute to allergy in a PAR-2-independent manner. Patient investigations have confirmed these abnormalities and revealed a wide spectrum of disease expression, sometimes associated with residual LEKTI expression. These results have demonstrated that the tight regulation of epidermal protease activity is essential for skin homeostasis and identified new targets for therapeutic intervention. They also provide a link with atopic dermatitis through deregulated protease activity, as recently supported by functional studies of the E420K LEKTI variant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Allen A, Siegfried E, Silverman R, Williams ML, Elias PM, Szabo SK, Korman NJ (2001) Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 137:747–750

    PubMed  CAS  Google Scholar 

  • Alpigiani MG, Salvati P, Schiaffino MC, Occella C, Castiglia D, Covaciu C, Lorini R (2012) A new SPINK5 mutation in a patient with Netherton syndrome: a case report. Pediatr Dermatol 29:521–522

    Article  PubMed  Google Scholar 

  • Andre E, Till M, Descargues P, Cordier MP, Fouilhoux A, Haftek M, Hovnanian A, Lachaux A (2005) Netherton syndrome: a type of infantile erythroderma with failure to thrive, immune deficiency, rickets. Report of 3 cases. Arch Pediatr 12:1364–1367

    Article  PubMed  CAS  Google Scholar 

  • Bennett K, Callard R, Heywood W, Harper J, Jayakumar A, Clayman GL, Di WL, Mills K (2010) New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI. J Proteome Res 9:4289–4294

    Article  PubMed  CAS  Google Scholar 

  • Bennett K, Heywood W, Di WL, Harper J, Clayman GL, Jayakumar A, Callard R, Mills K (2012) The identification of a new role for LEKTI in the skin: the use of protein “bait” arrays to detect defective trafficking of dermcidin in the skin of patients with Netherton syndrome. J Proteomics 75:3925–3937

    Article  PubMed  CAS  Google Scholar 

  • Bitoun E, Bodemer C, Amiel J, de Prost Y, Stoll C, Calvas P, Hovnanian A (2002a) Prenatal diagnosis of a lethal form of Netherton syndrome by SPINK5 mutation analysis. Prenat Diagn 22:121–126

    Article  PubMed  CAS  Google Scholar 

  • Bitoun E, Chavanas S, Irvine AD, Lonie L, Bodemer C, Paradisi M, Hamel-Teillac D, Ansai S, Mitsuhashi Y, Taieb A et al (2002b) Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol 118:352–361

    Article  PubMed  CAS  Google Scholar 

  • Bitoun E, Micheloni A, Lamant L, Bonnart C, Tartaglia-Polcini A, Cobbold C, Al Saati T, Mariotti F, Mazereeuw-Hautier J, Boralevi F et al (2003) LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum Mol Genet 12:2417–2430

    Article  PubMed  CAS  Google Scholar 

  • Bonnart C, Deraison C, Lacroix M, Hovnanian A (2010a) Elastase 2, a key player in the integrity of the epidermal barrier and in Netherton syndrome. Med Sci (Paris) 26:681–685

    Article  Google Scholar 

  • Bonnart C, Deraison C, Lacroix M, Uchida Y, Besson C, Robin A, Briot A, Gonthier M, Lamant L, Dubus P et al (2010b) Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 120:871–882

    Article  PubMed  CAS  Google Scholar 

  • Borgono CA, Michael IP, Komatsu N, Jayakumar A, Kapadia R, Clayman GL, Sotiropoulou G, Diamandis EP (2007) A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 282:3640–3652

    Article  PubMed  CAS  Google Scholar 

  • Briot A, Deraison C, Lacroix M, Bonnart C, Robin A, Besson C, Dubus P, Hovnanian A (2009) Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 206:1135–1147

    Article  PubMed  CAS  Google Scholar 

  • Briot A, Lacroix M, Robin A, Steinhoff M, Deraison C, Hovnanian A (2010) Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model. J Invest Dermatol 130:2736–2742

    Article  PubMed  CAS  Google Scholar 

  • Chao SC, Tsai YM, Lee JY (2003) A compound heterozygous mutation of the SPINK5 gene in a Taiwanese boy with Netherton syndrome. J Formos Med Assoc 102:418–423

    PubMed  CAS  Google Scholar 

  • Chao SC, Richard G, Lee JY (2005) Netherton syndrome: report of two Taiwanese siblings with staphylococcal scaled skin syndrome and mutation of SPINK5. Br J Dermatol 152:159–165

    Article  PubMed  Google Scholar 

  • Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafe JL, Wilkinson J, Taieb A, Barrandon Y et al (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141–142

    Article  PubMed  CAS  Google Scholar 

  • Comel M (1949) Ichthyosis linearis circumflexa. Dermatologica 98:133–136

    Article  PubMed  CAS  Google Scholar 

  • Cui CY, Aragane Y, Maeda A, Piao YL, Takahashi M, Kim LH, Tezuka T (1999) Bikunin, a serine protease inhibitor, is present on the cell boundary of epidermis. J Invest Dermatol 113:182–188

    Article  PubMed  CAS  Google Scholar 

  • Deraison C, Bonnart C, Lopez F, Besson C, Robinson R, Jayakumar A, Wagberg F, Brattsand M, Hachem JP, Leonardsson G et al (2007) LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol Cell 18:3607–3619

    Article  PubMed  CAS  Google Scholar 

  • Descargues P, Deraison C, Bonnart C, Kreft M, Kishibe M, Ishida-Yamamoto A, Elias P, Barrandon Y, Zambruno G, Sonnenberg A et al (2005) Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 37:56–65

    PubMed  CAS  Google Scholar 

  • Descargues P, Deraison C, Prost C, Fraitag S, Mazereeuw-Hautier J, D’Alessio M, Ishida-Yamamoto A, Bodemer C, Zambruno G, Hovnanian A (2006) Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome. J Invest Dermatol 126:1622–1632

    Article  PubMed  CAS  Google Scholar 

  • Di WL, Larcher F, Semenova E, Talbot GE, Harper JI, Del Rio M, Thrasher AJ, Qasim W (2011a) Ex-vivo gene therapy restores LEKTI activity and corrects the architecture of Netherton syndrome-derived skin grafts. Mol Ther 19:408–416

    Article  PubMed  CAS  Google Scholar 

  • Di WL, Semenova E, Larcher F, Del Rio M, Harper JI, Thrasher A, Qasim W (2011b) Human involucrin promoter mediates repression resistant and compartment specific LEKTI expression. Hum Gene Ther 23:83–90

    Article  Google Scholar 

  • Egelrud T, Brattsand M, Kreutzmann P, Walden M, Vitzithum K, Marx UC, Forssmann WG, Magert HJ (2005) hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br J Dermatol 153:1200–1203

    Article  PubMed  CAS  Google Scholar 

  • Elias PM, Schmuth M (2009) Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol 9:437–446

    Article  PubMed  CAS  Google Scholar 

  • Folster-Holst R, Swensson O, Stockfleth E, Monig H, Mrowietz U, Christophers E (1999) Comel-Netherton syndrome complicated by papillomatous skin lesions containing human papillomaviruses 51 and 52 and plane warts containing human papillomavirus 16. Br J Dermatol 140:1139–1143

    Article  PubMed  CAS  Google Scholar 

  • Fong K, Akdeniz S, Isi H, Taskesen M, McGrath JA, Lai-Cheong JE (2010) New homozygous SPINK5 mutation, p.Gln333X, in a Turkish pedigree with Netherton syndrome. Clin Exp Dermatol 36:412–415

    Article  PubMed  Google Scholar 

  • Fontao L, Laffitte E, Briot A, Kaya G, Roux-Lombard P, Fraitag S, Hovnanian AA, Saurat JH (2011) Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a reduction of thymic stromal lymphopoietin levels in the skin. J Invest Dermatol 131:1947–1950

    Article  PubMed  CAS  Google Scholar 

  • Fortugno P, Bresciani A, Paolini C, Pazzagli C, El Hachem M, D’Alessio M, Zambruno G (2011) Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis. J Invest Dermatol 131:2223-2232

    Google Scholar 

  • Fortugno P, Furio L, Teson M, Berretti M, El Hachem M, Zambruno G, Hovnanian A, D’Alessio M (2012) The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis. Hum Mol Genet 21:4187–4200

    Article  PubMed  CAS  Google Scholar 

  • Furio L, Hovnanian A (2011) When activity requires breaking up: LEKTI proteolytic activation cascade for specific proteinase inhibition. J Invest Dermatol 131:2169–2173

    Article  PubMed  CAS  Google Scholar 

  • Garty BZ, Nimri R (2008) Hypothyroidism in Netherton syndrome. Pediatr Dermatol 25:134–135

    Article  PubMed  Google Scholar 

  • Goujon E, Beer F, Fraitag S, Hovnanian A, Vabres P (2010) “Matchstick” eyebrow hairs: a dermoscopic clue to the diagnosis of Netherton syndrome. J Eur Acad Dermatol Venereol 24:740–741

    Article  PubMed  CAS  Google Scholar 

  • Hachem JP, Wagberg F, Schmuth M, Crumrine D, Lissens W, Jayakumar A, Houben E, Mauro TM, Leonardsson G, Brattsand M et al (2006) Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol 126:1609–1621

    Article  PubMed  CAS  Google Scholar 

  • Hausser I, Anton-Lamprecht I (1996) Severe congenital generalized exfoliative erythroderma in newborns and infants: a possible sign of Netherton syndrome. Pediatr Dermatol 13:183–199

    Article  PubMed  CAS  Google Scholar 

  • Hewett DR, Simons AL, Mangan NE, Jolin HE, Green SM, Fallon PG, McKenzie AN (2005) Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome. Hum Mol Genet 14:335–346

    Article  PubMed  CAS  Google Scholar 

  • Hintner H, Jaschke E, Fritsch P (1980) Netherton syndrome: weakened immunity, generalized verrucosis and carcinogenesis. Hautarzt 31:428–432

    PubMed  CAS  Google Scholar 

  • Hosomi N, Fukai K, Nakanishi T, Funaki S, Ishii M (2008) Caspase-1 activity of stratum corneum and serum interleukin-18 level are increased in patients with Netherton syndrome. Br J Dermatol 159:744–746

    PubMed  CAS  Google Scholar 

  • Hovnanian A (2012) Netherton syndrome: new advances in the clinic, disease mechanism and treatment. Expert Rev Dermatol 7:69–80

    Article  Google Scholar 

  • Jayakumar A, Kang Y, Mitsudo K, Henderson Y, Frederick MJ, Wang M, El-Naggar AK, Marx UC, Briggs K, Clayman GL (2004) Expression of LEKTI domains 6-9′ in the baculovirus expression system: recombinant LEKTI domains 6-9′ inhibit trypsin and subtilisin A. Protein Expr Purif 35:93–101

    Article  PubMed  CAS  Google Scholar 

  • Judge MR, Morgan G, Harper JI (1994) A clinical and immunological study of Netherton’s syndrome. Br J Dermatol 131:615–621

    Article  PubMed  CAS  Google Scholar 

  • Kabesch M, Carr D, Weiland SK, Mutius E von (2004) Association between polymorphisms in serine protease inhibitor, kazal type 5 and asthma phenotypes in a large German population sample. Clin Exp Allergy J Br Soc Allergy Clin Immunol 34:340–345

    Google Scholar 

  • Kato A, Fukai K, Oiso N, Hosomi N, Murakami T, Ishii M (2003) Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol 148:665–669

    Article  PubMed  CAS  Google Scholar 

  • Krasagakis K, Ioannidou DJ, Stephanidou M, Manios A, Panayiotides JG, Tosca AD (2003) Early development of multiple epithelial neoplasms in Netherton syndrome. Dermatology 207:182–184

    Article  PubMed  CAS  Google Scholar 

  • Kreutzmann P, Schulz A, Standker L, Forssmann WG, Magert HJ (2004) Recombinant production, purification and biochemical characterization of domain 6 of LEKTI: a temporary Kazal-type-related serine proteinase inhibitor. J Chromatogr B Analyt Technol Biomed Life Sci 803:75–81

    Article  PubMed  CAS  Google Scholar 

  • Kubler HC, Kuhn W, Rummel HH, Kaufmann I, Kaufmann M (1987) Development of cancer (vulvar cancer) in the Netherton syndrome (ichthyosis, hair anomalies, atopic diathesis). Geburtshilfe Frauenheilkd 47:742–744

    Article  PubMed  CAS  Google Scholar 

  • Kusunoki T, Okafuji I, Yoshioka T, Saito M, Nishikomori R, Heike T, Sugai M, Shimizu A, Nakahata T (2005) SPINK5 polymorphism is associated with disease severity and food allergy in children with atopic dermatitis. J Allergy Clin Immunol 115:636–638

    Article  PubMed  CAS  Google Scholar 

  • Lacroix M, Lacaze-Buzy L, Furio L, Tron E, Valari M, Van de Wier G, Bodemer C, Bygum A, Bursztejn A-C, Gaitanis G et al (2011) Clinical expression and new SPINK5 splicing defects in Netherton syndrome: unmasking a frequent founder synonymous mutation and unconventional intronic mutations. J Invest Dermatol 132:575–582

    Google Scholar 

  • Lacroix M, Lacaze-Buzy L, Furio L, Tron E, Valari M, Van der Wier G, Bodemer C, Bygum A, Bursztejn AC, Gaitanis G et al (2012) Clinical expression and new SPINK5 splicing defects in Netherton syndrome: unmasking a frequent founder synonymous mutation and unconventional intronic mutations. J Invest Dermatol 132:575–582

    Article  PubMed  CAS  Google Scholar 

  • Li AL, Walsh S, McKay DR (2011) Surgical management of a giant condyloma of Buschke-Lowenstein in a patient with Netherton syndrome using the pedicled anterolateral thigh flap—a case report. J Plast Reconstr Aesthet Surg 64:1533–1536

    Article  PubMed  Google Scholar 

  • Lin SP, Huang SY, Tu ME, Wu YH, Lin CY, Lin HY, Lee-Chen GJ (2007) Netherton syndrome: mutation analysis of two Taiwanese families. Arch Dermatol Res 299:145–150

    Article  PubMed  Google Scholar 

  • Macknet CA, Morkos A, Job L, Garberoglio MC, Clark RD, Macknet KD Jr, Peverini RL (2008) An infant with Netherton syndrome and persistent pulmonary hypertension requiring extracorporeal membrane oxygenation. Pediatr Dermatol 25:368–372

    Article  PubMed  Google Scholar 

  • Magert HJ, Standker L, Kreutzmann P, Zucht HD, Reinecke M, Sommerhoff CP, Fritz H, Forssmann WG (1999) LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem 274:21499–21502

    Article  PubMed  CAS  Google Scholar 

  • Magert HJ, Kreutzmann P, Drogemuller K, Standker L, Adermann K, Walden M, John H, Korting HC, Forssmann WG (2002a) The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role. Eur J Med Res 7:49–56

    PubMed  CAS  Google Scholar 

  • Magert HJ, Kreutzmann P, Standker L, Walden M, Drogemuller K, Forssmann WG (2002b) LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance. Int J Biochem Cell Biol 34:573–576

    Article  PubMed  CAS  Google Scholar 

  • Mazereeuw-Hautier J, Cope J, Ong C, Green A, Hovnanian A, Harper JI (2006) Topical recombinant alpha1-antitrypsin: a potential treatment for Netherton syndrome? Arch Dermatol 142:396–398

    PubMed  Google Scholar 

  • Meyer-Hoffert U, Wu Z, Schroder JM (2009) Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor. PLoS One 4:e4372

    Article  PubMed  Google Scholar 

  • Meyer-Hoffert U, Wu Z, Kantyka T, Fischer J, Latendorf T, Hansmann B, Bartels J, He Y, Glaser R, Schroder JM (2010) Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases. J Biol Chem 285:32174–32181

    Article  PubMed  CAS  Google Scholar 

  • Mitsudo K, Jayakumar A, Henderson Y, Frederick MJ, Kang Y, Wang M, El-Naggar AK, Clayman GL (2003) Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis. Biochemistry 42:3874–3881

    Article  PubMed  CAS  Google Scholar 

  • Mizuno Y, Suga Y, Muramatsu S, Hasegawa T, Shimizu T, Ogawa H (2005) A Japanese infant with localized ichthyosis linearis circumflexa on the palms and soles harbouring a compound heterozygous mutation in the SPINK5 gene. Br J Dermatol 153:661–663

    Article  PubMed  CAS  Google Scholar 

  • Mizuno Y, Suga Y, Haruna K, Muramatsu S, Hasegawa T, Kohroh K, Shimizu T, Komatsu N, Ogawa H, Ikeda S (2006) A case of a Japanese neonate with congenital ichthyosiform erythroderma diagnosed as Netherton syndrome. Clin Exp Dermatol 31:677–680

    Article  PubMed  CAS  Google Scholar 

  • Netherton EW (1958) A unique case of trichorrhexis nodosa: bamboo hairs. AMA Arch Derm 78:483–487

    Article  PubMed  CAS  Google Scholar 

  • Nishio Y, Noguchi E, Shibasaki M, Kamioka M, Ichikawa E, Ichikawa K, Umebayashi Y, Otsuka F, Arinami T (2003) Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese. Genes Immun 4:515–517

    Article  PubMed  CAS  Google Scholar 

  • Oji V, Beljan G, Beier K, Traupe H, Luger TA (2005) Topical pimecrolimus: a novel therapeutic option for Netherton syndrome. Br J Dermatol 153:1067–1068

    Article  PubMed  CAS  Google Scholar 

  • Ong C, Harper J (2006) Netherton’s syndrome. In: Harper J, Orange A, Prose N (eds) Textbook of pediatric dermatology. Blackwell, Turin, pp 1359–1366

    Google Scholar 

  • Ong C, O’Toole EA, Ghali L, Malone M, Smith VV, Callard R, Harper JI (2004) LEKTI demonstrable by immunohistochemistry of the skin: a potential diagnostic skin test for Netherton syndrome. Br J Dermatol 151:1253–1257

    Article  PubMed  CAS  Google Scholar 

  • Pohl M, Zimmerhackl LB, Hausser I, Ludwig H, Hildebrandt F, Gordjani N, Sutor AH, Anton-Lamprecht I, Brandis M (1998) Acute bilateral renal vein thrombosis complicating Netherton syndrome. Eur J Pediatr 157:157–160

    Article  PubMed  CAS  Google Scholar 

  • Raghunath M, Tontsidou L, Oji V, Aufenvenne K, Schurmeyer-Horst F, Jayakumar A, Stander H, Smolle J, Clayman GL, Traupe H (2004) SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases. J Invest Dermatol 123:474–483

    Article  PubMed  CAS  Google Scholar 

  • Renner ED, Hartl D, Rylaarsdam S, Young ML, Monaco-Shawver L, Kleiner G, Markert ML, Stiehm ER, Belohradsky BH, Upton MP et al (2009) Comel-Netherton syndrome defined as primary immunodeficiency. J Allergy Clin Immunol 124:536–543

    Article  PubMed  CAS  Google Scholar 

  • Roedl D, Oji V, Buters JT, Behrendt H, Braun-Falco M (2011) rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients. J Dermatol Sci 61:194–198

    Article  PubMed  CAS  Google Scholar 

  • Saghari S, Woolery-Lloyd H, Nouri K (2002) Squamous cell carcinoma in a patient with Netherton’s syndrome. Int J Dermatol 41:415–416

    Article  PubMed  Google Scholar 

  • Saif GB, Al-Khenaizan S (2007) Netherton syndrome: successful use of topical tacrolimus and pimecrolimus in four siblings. Int J Dermatol 46:290–294

    Article  PubMed  Google Scholar 

  • Schalkwijk J, Chang A, Janssen P, De Jongh GJ, Mier PD (1990) Skin-derived antileucoproteases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis. Br J Dermatol 122:631–641

    Article  PubMed  CAS  Google Scholar 

  • Schechter NM, Choi EJ, Wang ZM, Hanakawa Y, Stanley JR, Kang Y, Clayman GL, Jayakumar A (2005) Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI). Biol Chem 386:1173–1184

    Article  PubMed  CAS  Google Scholar 

  • Shimomura Y, Sato N, Kariya N, Takatsuka S, Ito M (2005) Netherton syndrome in two Japanese siblings with a novel mutation in the SPINK5 gene: immunohistochemical studies of LEKTI and other epidermal molecules. Br J Dermatol 153:1026–1030

    Article  PubMed  CAS  Google Scholar 

  • Soreide K, Soiland H, Korner H, Haga H, Soreide JA (2005) Acute pancreatitis in a young girl with the Netherton syndrome. J Pediatr Surg 40:e69–e72

    Article  PubMed  Google Scholar 

  • Sprecher E, Chavanas S, DiGiovanna JJ, Amin S, Nielsen K, Prendiville JS, Silverman R, Esterly NB, Spraker MK, Guelig E et al (2001) The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J Invest Dermatol 117:179–187

    Article  PubMed  CAS  Google Scholar 

  • Sprecher E, Tesfaye-Kedjela A, Ratajczak P, Bergman R, Richard G (2004) Deleterious mutations in SPINK5 in a patient with congenital ichthyosiform erythroderma: molecular testing as a helpful diagnostic tool for Netherton syndrome. Clin Exp Dermatol 29:513–517

    Article  PubMed  CAS  Google Scholar 

  • Stryk S, Siegfried EC, Knutsen AP (1999) Selective antibody deficiency to bacterial polysaccharide antigens in patients with Netherton syndrome. Pediatr Dermatol 16:19–22

    Article  PubMed  CAS  Google Scholar 

  • Sun JD, Linden KG (2006) Netherton syndrome: a case report and review of the literature. Int J Dermatol 45:693–697

    Article  PubMed  Google Scholar 

  • Szabo R, Kosa P, List K, Bugge TH (2009) Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality. Am J Pathol 174:2015–2022

    Article  PubMed  CAS  Google Scholar 

  • Tartaglia-Polcini A, Bonnart C, Micheloni A, Cianfarani F, Andre A, Zambruno G, Hovnanian A, D’Alessio M (2006) SPINK5, the defective gene in Netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing. J Invest Dermatol 126:315–324

    Article  PubMed  CAS  Google Scholar 

  • Traupe H (1989) The Comel-Netherton syndrome. In: Traupe H (ed) The ichthyoses: a guide to clinical diagnosis, genetic counseling and therapy. Springer, Berlin, pp 168–178

    Google Scholar 

  • Van Gysel D, Koning H, Baert MR, Savelkoul HF, Neijens HJ, Oranje AP (2001) Clinico-immunological heterogeneity in Comel-Netherton syndrome. Dermatology 202:99–107

    Article  PubMed  Google Scholar 

  • Walley AJ, Chavanas S, Moffatt MF, Esnouf RM, Ubhi B, Lawrence R, Wong K, Abecasis GR, Jones EY, Harper JI et al (2001) Gene polymorphism in Netherton and common atopic disease. Nat Genet 29:175–178

    Article  PubMed  CAS  Google Scholar 

  • Weber F, Fuchs PG, Pfister HJ, Hinter H, Fritsch P, Hoepfl R (2001) Human papillomavirus infection in Nehterton’s syndrome. Br J Dermatol 144:1044–1049

    Article  PubMed  CAS  Google Scholar 

  • Weidinger S, Baurecht H, Wagenpfeil S, Henderson J, Novak N, Sandilands A, Chen H, Rodriguez E, O’Regan GM, Watson R et al (2008) Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk. J Allergy Clin Immunol 122:e564

    Article  Google Scholar 

  • Wingens M, Bergen BH van, Hiemstra PS, Meis JF, Vlijmen-Willems IM van, Zeeuwen PL, Mulder J, Kramps HA, Ruissen F van, Schalkwijk J (1998) Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J Invest Dermatol 111:996–1002

    Google Scholar 

  • Xiang NN, Di W-L (2012) Therapeutic interventions for Netherton syndrome. Expert Rev Dermatol 7:319–321

    Article  CAS  Google Scholar 

  • Yan AC, Honig PJ, Ming ME, Weber J, Shah KN (2010) The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. Arch Dermatol 146:57–62

    Article  PubMed  CAS  Google Scholar 

  • Yang T, Liang D, Koch PJ, Hohl D, Kheradmand F, Overbeek PA (2004) Epidermal detachment, desmosomal dissociation, and destabilization of corneodesmosin in Spink5-/- mice. Genes Dev 18:2354–2358

    Article  PubMed  CAS  Google Scholar 

  • Zhao LP, Di Z, Zhang L, Wang L, Ma L, Lv Y, Hong Y, Wei H, Chen HD, Gao XH (2011) Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China. J Eur Acad Dermatol Venereol 26:572–577

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Genetic Skin Diseases, INSERM U781, Paris, France

    Alain Hovnanian

  2. Imagine Institute for Genetic Diseases, Paris, 75015, France

    Alain Hovnanian

  3. University René Descartes, Sorbonne Paris Cité, Paris, France

    Alain Hovnanian

  4. Department of Genetics, Tour Lavoisier, 3ème étage, Hôpital Necker Enfants-malades, 149 Rue de Sèvres, 75743, Paris, cedex 15, France

    Alain Hovnanian

Authors
  1. Alain Hovnanian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alain Hovnanian.

Additional information

The work presented here was in part funded by the Fondation pour la Recherche Médicale and the Agence Nationale pour la Recherche.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hovnanian, A. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition. Cell Tissue Res 351, 289–300 (2013). https://doi.org/10.1007/s00441-013-1558-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00441-013-1558-1

Keywords

Search

Navigation